Pharma

Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system.

DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers.

Verily researchers have built prototype devices for painless blood collection that uses a system of “exploding” micro-needles, magnets, and potentially a blood storage chamber, CNBC reports.

Garmin and the University of Kansas Medical Center are taking a closer look at the role wearables can play in detecting and managing medical conditions, the groups announced earlier this week.

In a recent medium.

Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends.

Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.

Pharma companies have been eying digital health with interest, and the first quarter of 2018 was no exception.

ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph.

Five healthcare organizations including insurers UnitedHealthcare and Humana, Optum, Quest Diagnostics, and MultiPlan are launching a blockchain pilot to help payers tackle mandated provider directories.